NERLYNX Trademark

Trademark Overview

On Tuesday, June 30, 2015, a trademark application was filed for NERLYNX with the United States Patent and Trademark Office. The USPTO has given the NERLYNX trademark a serial number of 86678985. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, February 20, 2024. This trademark is owned by Puma Biotechnology Inc.. The NERLYNX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the prevention and treatment of cancer
nerlynx

General Information

Serial Number86678985
Word MarkNERLYNX
Filing DateTuesday, June 30, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, February 20, 2024
Registration Number5311871
Registration DateTuesday, October 17, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 17, 2015

Trademark Statements

Goods and ServicesPharmaceutical products for the prevention and treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 7, 2015
Primary Code005
First Use Anywhere DateMonday, July 24, 2017
First Use In Commerce DateMonday, July 24, 2017

Trademark Owner History

Party NamePuma Biotechnology Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90024
Party NamePuma Biotechnology Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90024
Party NamePuma Biotechnology Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90024

Trademark Events

Event DateEvent Description
Tuesday, February 20, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, February 20, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, February 20, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, September 1, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, October 17, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, August 4, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, October 17, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, September 12, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, September 11, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, August 19, 2017STATEMENT OF USE PROCESSING COMPLETE
Thursday, July 27, 2017USE AMENDMENT FILED
Friday, August 18, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 27, 2017TEAS STATEMENT OF USE RECEIVED
Wednesday, July 12, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 10, 2017SOU EXTENSION 3 GRANTED
Monday, July 10, 2017SOU EXTENSION 3 FILED
Monday, July 10, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, November 30, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 28, 2016SOU EXTENSION 2 GRANTED
Monday, November 28, 2016SOU EXTENSION 2 FILED
Monday, November 28, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, June 22, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 20, 2016SOU EXTENSION 1 GRANTED
Monday, June 20, 2016SOU EXTENSION 1 FILED
Monday, June 20, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, January 12, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 17, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 17, 2015PUBLISHED FOR OPPOSITION
Wednesday, October 28, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 8, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 8, 2015ASSIGNED TO EXAMINER
Tuesday, July 7, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 3, 2015NEW APPLICATION ENTERED

Related Keywords

nerlynx cancer treatment prevention products pharmaceutical